Biotech ETF Nears a Critical Juncture

Biotechnology stocks and exchange traded funds have experienced an eventful 2014 with plenty of focus on the group’s jaw-dropping March/April tumble. From its late February peak to its April 11 trough, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotech ETF by assets, plunged...